CIPLA FDA Approval ANDA 206046

ANDA 206046

CIPLA

FDA Drug Application

Application #206046

Application Sponsors

ANDA 206046CIPLA

Marketing Status

Discontinued001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 0.1% BASE0OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-07-26STANDARD
LABELING; LabelingSUPPL2AP2020-12-18STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null31

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206046
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"OLOPATADINE HYDROCHLORIDE","activeIngredients":"OLOPATADINE HYDROCHLORIDE","strength":"EQ 0.1% BASE","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/26\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-07-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.